:quality(80)/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/27df33e4-c5eb-4dc8-805e-babc7c688b65.jpg)
Fresenius SE Aims to Improve Its Profitability
Fresenius SE’s prowess in dialysis and injectable therapies has created opportunities to vertically integrate into several medical service and technology businesses by organic and inorganic means.
Fresenius SE & Co KGaA FRE
Bulls Say, Bears Say
Bulls
Underlying demographic trends and international expansion opportunities should keep Fresenius’ dialysis services and related medical product growth in positive territory as the pandemic recedes.
Bears
Until the US achieves universal affordable coverage, policy risks around reimbursement for dialysis services may continue to add risk to the story.
News
Trading Information
- Previous Close Price
- €33.96
- Day Range
- €33.90–34.39
- 52-Week Range
- €23.93–35.03
- Bid/Ask
- €33.90 / €33.92
- Market Cap
- €19.11 Bil
- Volume/Avg
- 670,445 / 896,083
Key Statistics
- Price/Earnings (Normalized)
- 6.38
- Price/Sales
- 0.87
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Large Core
- Total Number of Employees
- 175,771
- Website
- https://www.fresenius.com
Competitors
Valuation
|
Metric
|
FRE
|
BAX
|
DVA
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.38 | 12.14 | 16.42 |
Price/Book Value | 1.00 | 2.34 | 21.38 |
Price/Sales | 0.87 | 1.19 | 1.16 |
Price/Cash Flow | 26.42 | 11.70 | 7.08 |
Price/Earnings
FRE
BAX
DVA
Financial Strength
|
Metric
|
FRE
|
BAX
|
DVA
|
|---|---|---|---|
Quick Ratio | 0.70 | 0.77 | 1.06 |
Current Ratio | 1.29 | 1.40 | 1.16 |
Interest Coverage | 2.72 | 0.63 | 4.60 |
Quick Ratio
FRE
BAX
DVA
Profitability
|
Metric
|
FRE
|
BAX
|
DVA
|
|---|---|---|---|
Return on Assets (Normalized) | 2.86% | 5.24% | 7.26% |
Return on Equity (Normalized) | 8.35% | 19.49% | 128.03% |
Return on Invested Capital (Normalized) | 4.82% | 7.74% | 11.03% |
Return on Assets
FRE
BAX
DVA
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| HCA Healthcare Inc
HCA
| Ztpqtznh | Lxlyr | $101.3 Bil | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | Rbzrd | $21.1 Bil | |||
| Fresenius SE & Co KGaA
FSNUF
| — | Xmlpt | $21.1 Bil | |||
| Tenet Healthcare Corp
THC
| Wlxbzgr | Fkwh | $15.0 Bil | |||
| Universal Health Services Inc Class B
UHS
| — | Ssygpmm | $14.4 Bil | |||
| Bangkok Dusit Medical Services PCL ADR
BDUUY
| — | Vdmf | $14.2 Bil | |||
| DaVita Inc
DVA
| Yrwybmwsd | Mtgsd | $13.3 Bil | |||
| Fresenius Medical Care AG
FMCQF
| — | Cqmdlcn | $12.2 Bil | |||
| Fresenius Medical Care AG ADR
FMS
| Slxm | Mlmgdv | $12.2 Bil | |||
| Encompass Health Corp
EHC
| — | Dqkdpwn | $9.5 Bil |
United States